This example shows trial design and results data for in vitro Neutral Red Uptake Cytotoxicity Assay, Relative Absorbance.
...
Note that Variable Names and Domain abbreviations may change (have not been checked against existing and are not vetted)
...
.
| Expand |
|---|
| title | Study 123, Report Table |
|---|
|
The following shows the tabulated data as it is represented in a report for this study. This report includes summary statistics (e.g. Average, Standard Deviation, Coeff. Var.); however, statistics are not included in the SEND standard and will not be represented in the SEND domains example. Neutral Red Cytotoxicity Assay Results (Relative Absorbance Data) |
|
| Run-Port Number | Sample ID | Smoke Fraction | Replicate Number | Plate Number | Well Number |
| Relative Assay Plate Absorbance Readings |
|
|
| Cigarette Smoke Condensate (µg/mL) | SLS (µg/mL) |
| EC50 (µg/ml) | 0 | 10 | 50 | 75 | 100 | 120 | 140 | 160 | 200 | 110 | 200 | 0 |
| | 1-1 | 030001 | A | 1 | 1 | 1 | 0.046
| 0.046* | 0.039* | 0.012* | 0.030* | 0.003* | 0.057* | 0.032* | 0.003* | 0.050* | 0.044* | 0.040 |
| 1-1 | 030001 | A | 1 | 1 | 2 | 0.048 | 107 | 77.7 | 65.7 | 30.2 | 15.6 | 9.79 | 5.41 | 2.49 | 8.09 | 0.791 | 0.014 |
| 1-1 | 030001 | A | 1 | 1 | 3 | 0.005 | 98.6 | 77.4 | 57.7 | 35.8 | 8.09 | 7.36 | 3.22 | 0.791 | 6.38 | 0.061 | 0.050 |
| 1-1 | 030001 | A | 1 | 1 | 4 | 0.049 | 94.9 | 81.5 | 38.2 | 31.2 | 7.60 | 5.17 | 3.22 | 0.791 | 5.17 | 0.304 | 0.017 |
| 1-1 | 030001 | A | 1 | 1 | 5 | 0.047 | 111 | 78.1 | 64.5 | 32.9 | 8.82 | 5.90 | 2.74 | 1.28 | 10.3 | 0.547 | 0.011 |
| 1-1 | 030001 | A | 1 | 1 | 6 | 0.032 | 96.6 | 76.2 | 48.0 | 26.8 | 7.84 | 4.20 | 2.74 | 1.52 | 8.09 | 4.93 | 0.022 |
| 1-1 | 030001 | A | 1 | 1 | 7 | 0.044 | 105 | 77.9 | 58.2 | 28.3 | 8.09 | 4.68 | 1.76 | 0.547 | 8.57 | 1.76 | 0.056 |
| 1-1 | 030001 | A | 1 | 1 | 8 | 0.056 | 0.013* | 0.040* | 0.008* | 0.013* | 0.002* | 0.029* | 0.018* | 0.006* | 0.016* | 0.024* | 0.046 |
| Average |
| 101 | 78.2 | 54.5 | 29.9 | 9.70 | 6.17 | 3.37 | 1.19 | 8.94 | 1.22 |
|
| Std. Dev. |
| 6 | 2.9 | 9.4 | 3.6 | 2.95 | 2.19 | 1.12 | 0.72 | 2.72 | 1.58 |
|
| Coeff. Var. |
| 5.8 | 3.6 | 17.2 | 11.9 | 30.4 | 35.5 | 33.1 | 61.0 | 30.5 | 129.9 |
|
| *non-treated control wells |
|
|
|
|
|
|
|
|
|
|
|
|
| 1-1 | 030001 | A | 1 | 2 | 1 |
| 93.4 | 74.0 | 56.0 | 35.1 | 11.8 | 8.70 | 5.10 | 1.98 | 5.34 | 1.02 |
|
| 1-1 | 030001 | A | 1 | 2 | 2 |
| 102 | 75.2 | 53.3 | 35.1 | 11.8 | 7.74 | 5.58 | 3.66 | 5.34 | 1.02 |
|
| 1-1 | 030001 | A | 1 | 2 | 3 |
| 107 | 79.0 | 55.0 | 26.5 | 10.1 | 6.06 | 3.66 | 1.74 | 7.02 | 0.780 |
|
| 1-1 | 030001 | A | 1 | 2 | 4 |
| 104 | 80.2 | 55.3 | 29.8 | 8.94 | 3.90 | 3.66 | 1.50 | 6.30 | 0.780 |
|
| 1-1 | 030001 | A | 1 | 2 | 5 |
| 101 | 75.7 | 54.1 | 26.7 | 4.86 | 4.38 | 1.26 | 1.02 | 6.30 | 1.02 |
|
| 1-1 | 030001 | A | 1 | 2 | 6 |
| 110 | 85.7 | 67.7 | 26.0 | 5.34 | 4.62 | 3.42 | 1.50 | 6.30 | 0.540 |
|
| 1-1 | 030001 | A | 1 | 2 | 7 |
| 104 | 77.8 | 64.9 | 27.7 | 8.22 | 3.18 | 2.46 | 1.02 | 6.30 | 0.780 |
|
| 1-1 | 030001 | A | 1 | 2 | 8 |
| 103 | 71.6 | 58.9 | 25.5 | 9.42 | 4.14 | 3.90 | 1.26 | 4.38 | 0.780 |
|
| Average |
| 103 | 77.4 | 58.1 | 29.0 | 8.82 | 5.34 | 3.63 | 1.71 | 5.91 | 0.840 |
|
| Std. Dev. |
| 5 | 4.4 | 5.3 | 4.0 | 2.63 | 1.97 | 1.37 | 0.86 | 0.83 | 0.170 |
|
| Coeff. Var. |
| 4.6 | 5.6 | 9.2 | 13.6 | 29.8 | 36.9 | 37.6 | 50.0 | 14.1 | 20.2 |
|
| EC50 (µg/ml). Effective concentration at 50% cytotoxicity. (using a specific sigmoidal equation = model). (could also be EC20 or EC30, EC70, etc.) |
|
|
|
|
|
|
|
|
|
|
|
| 123 |
|
...